Absci Investor Presentation Deck

AI DRIVEN LEAD OPTIMIZATION Multiparametric Al lead-optimization can enable higher potential therapeutics and increased Pos Find patient cohort specific targets ↓ Novel target discovery ai. ABSCI CORPORATION 2023 ALL RIGHTS RESERVED Discover novel antibodies Optimize antibodies' for selected target characteristics ↓ De novo discovery in silico EB ai. ↓ Lead optimization in silico y ai. Incorporate site-specific chemical handles ↓ Bionic SoluPro™ strain OPTIMAL DRUG CANDIDATE absci. 20

View entire presentation